These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 8817208
1. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma. van Hasselt EJ, Heij HA, de Kraker J, Vos A, Voûte PA. Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208 [Abstract] [Full Text] [Related]
2. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo"). Hoefnagel CA, de Kraker J, Voûte PA, Valdés Olmos RA. J Nucl Biol Med (1991); 1991 Jun; 35(4):248-51. PubMed ID: 1823828 [Abstract] [Full Text] [Related]
3. The treatment of neuroblastoma with [131I]MIBG at diagnosis. Troncone L, Rufini V, Luzi S, Mastrangelo R, Riccardi R. Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753 [Abstract] [Full Text] [Related]
5. [131I]MIBG as a first line treatment in advanced neuroblastoma. Hoefnagel CA, De Kraker J, Valdés Olmos RA, Voûte PA. Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752 [Abstract] [Full Text] [Related]
7. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma. Claudiani F, Garaventa A, Bertolazzi L, Villavecchia GP, Cabria M, Scopinaro G, Bestagno M, Guerra P, Canevarollo N, Scielzo G. J Nucl Biol Med (1991); 1991 Dec; 35(4):224-7. PubMed ID: 1823823 [Abstract] [Full Text] [Related]
8. Treatment of neuroblastoma with [131I]metaiodobenzylguanidine: long-term results in 25 patients. Klingebiel T, Feine U, Treuner J, Reuland P, Handgretinger R, Niethammer D. J Nucl Biol Med (1991); 1991 Dec; 35(4):216-9. PubMed ID: 1823821 [Abstract] [Full Text] [Related]
9. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma. Hoefnagel CA, Voûte PA, De Kraker J, Valdés Olmos RA. J Nucl Biol Med (1991); 1991 Dec; 35(4):202-6. PubMed ID: 1823819 [Abstract] [Full Text] [Related]
10. Long-term results of [131I]metaiodobenzylguanidine treatment of refractory advanced neuroblastoma. Hutchinson RJ, Sisson JC, Miser JS, Zasadny KR, Normolle DP, Shulkin BL, Francis IR, Wieland DM, Shapiro B. J Nucl Biol Med (1991); 1991 Dec; 35(4):237-40. PubMed ID: 1823826 [Abstract] [Full Text] [Related]
11. [131(I)-meta-iodobenzylguanidine treatment of 32 children with therapy-refractory neuroblastoma]. Berthold F, Feine U, Fischer M, Gerein V, Klingebiel T, Maul FD, Waters W, Wehinger H, Treuner J. Klin Padiatr; 1988 Dec; 200(3):226-9. PubMed ID: 3062260 [Abstract] [Full Text] [Related]
12. Outcome of [131I]metaiodobenzylguanidine therapy of neuroblastoma: seven years after. Hör G, Maul FD, Kornhuber B, Schwabe D, Hesse J, Manegold KH, Baüm RP, Gerein V. J Nucl Biol Med (1991); 1991 Dec; 35(4):207-15. PubMed ID: 1823820 [Abstract] [Full Text] [Related]
13. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma. Mastrangelo S, Tornesello A, Diociaiuti L, Riccardi R, Rufini V, Troncone L. Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754 [Abstract] [Full Text] [Related]
14. Experience with palliative [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma. Castellani MR, Rottoli L, Maffioli L, Massimino M, Gasparini M, Buraggi GL. J Nucl Biol Med (1991); 1991 Dec; 35(4):241-3. PubMed ID: 1726677 [Abstract] [Full Text] [Related]
15. Treatment of advanced neuroblastoma: feasibility and therapeutic potential of a novel approach combining 131-I-MIBG and multiple drug chemotherapy. Mastrangelo S, Tornesello A, Diociaiuti L, Pession A, Prete A, Rufini V, Troncone L, Mastrangelo R. Br J Cancer; 2001 Feb; 84(4):460-4. PubMed ID: 11207038 [Abstract] [Full Text] [Related]
16. [131I]metaiodobenzylguanidine and high-dose chemotherapy with bone marrow rescue in advanced neuroblastoma. Corbett R, Pinkerton R, Tait D, Meller S. J Nucl Biol Med (1991); 1991 Feb; 35(4):228-31. PubMed ID: 1823824 [Abstract] [Full Text] [Related]
17. The use of [131I]metaiodobenzylguanidine in the treatment of neuroblastoma after conventional therapy. Troncone L, Rufini V, Riccardi R, Lasorella A, Mastrangelo R. J Nucl Biol Med (1991); 1991 Feb; 35(4):232-6. PubMed ID: 1823825 [Abstract] [Full Text] [Related]
19. [Initial experiences in the treatment of children with metastatic and recurrent neuroblastoma using meta-iodobenzylguanidine]. Klingebiel T, Feine U, Niethammer D, Müller-Schauenburg W, Schwabe D, Maul FD, Gerein V, Fischer M, Gahr M, Kraz K. Klin Padiatr; 1986 Feb; 198(3):230-6. PubMed ID: 3723987 [Abstract] [Full Text] [Related]
20. Phase II study on the effect of disease sites, age, and prior therapy on response to iodine-131-metaiodobenzylguanidine therapy in refractory neuroblastoma. Matthay KK, Yanik G, Messina J, Quach A, Huberty J, Cheng SC, Veatch J, Goldsby R, Brophy P, Kersun LS, Hawkins RA, Maris JM. J Clin Oncol; 2007 Mar 20; 25(9):1054-60. PubMed ID: 17369569 [Abstract] [Full Text] [Related] Page: [Next] [New Search]